期刊文献+

FDG PET显像对非小细胞肺癌纵隔淋巴结转移的检测 被引量:9

下载PDF
导出
摘要 对非小细胞肺癌(NSCLC)患者,确定纵隔淋巴结转移与否对肿瘤的临床分期、选择合理的治疗方案有重要作用.对全身情况较好,未发现远处脏器和肺门淋巴结转移的NSCLC患者可首选外科手术治疗;对只有肺门淋巴结转移(N1)或有同侧纵隔淋巴结转移(N2)者,可在外科手术治疗后给予放疗或化疗;对有对侧纵隔淋巴结转移(N3)的患者,除少数可行手术治疗外,大部分不主张手术治疗,而行放疗和化疗为主的综合治疗.在体内病变的组织器官出现结构变化之前,18F-脱氧葡萄糖(FDG)PET显像可从分子水平检测和识别所发生的代谢改变.现将FDG PET显像在NSCLC纵隔淋巴结转移检测方面的研究综述如下.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2006年第2期120-122,共3页 Chinese Journal of Nuclear Medicine
基金 山东省医药卫生科研基金资助项目(2005HW137)
  • 相关文献

参考文献17

  • 1Prenzel KL,Monig SP,Sinning JM,et al.Lymph node size and metastatic infiltration in non-small cell lung cancer.Chest,2003,123:463 -467.
  • 2Verhagen AF,Bootsma GP,Tjan-Heijnen VC,et al.FDG PET in staging lung cancer:how does it change the algorithm? Lung Cancer,2004,44:175-181.
  • 3Kelly RF,Tran T,Holmstrom A,et al.Accuracy and cost-effectiveness of 18F-2-fluoro-deoxy-D-glucose positron emission tomography scan in potentially resectable non-small cell lung cancer.Chest,2004,125:1413-1423.
  • 4Gould MK,Kuschner WG,Rydzak CE,et al.Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer:a meta-analysis.Ann Intern Med,2003,139:879-892.
  • 5Weber WA,Dietlein M,Hellwig D,et al.PET with 18 F-fluorodeoxyglucose for staging of non-small cell lung cancer.Nuklearmedizin,2003,42:135-144.
  • 6Kernstine KH,Mclaughlin KA,Menda Y,et al.Can FDG PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer? Ann Thorac Surg,2002,73:394-401.
  • 7Konishi J,Yamazaki K,Tsukamoto E,et al.Mediastinal lymph node staging by FDG PET in patients with non-small cell lung cancer:analysis of false-positive FDG PET findings.Respiration,2003,70:500-506.
  • 8Takamochi K,Yoshida J,Murakami K,et al.Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.Lung Cancer,2005,47:235-242.
  • 9Chung JH,Cho KJ,Lee SS,et al.Overexpression of Glutl in lymphoid follicles correlates with false-positive 18F-FDG PET results in lung cancer staging.J Nucl Med,2004,45:999-1003.
  • 10Sasaki M,Kuwabara Y,Yoshida T,et al.Comparison of MET PET and FDG PET for differentiation between benign lesions and malignant tumors of the lung.Ann Nucl Med,2001,15:425-431.

二级参考文献22

  • 1孙晓蓉,邢力刚,于金明,付政,马莉,赵书强,陈鲁生,李文武,杨国仁.肺部肿瘤PET/CT同机图像融合精度研究[J].中华核医学杂志,2004,24(5):302-304. 被引量:11
  • 2Nakamoto Y, Tatsumi M, Cohade C, et al. Accuracy of image fusion of normal upper abdominal organs visualized with PET/CT. Eur J Nucl Med Mol Imaging, 2003, 30: 597-602.
  • 3Nakamoto Y, Osman M, Cohade C, etal. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuationcorrected images. J Nucl Med, 2002, 43: 1137-1143.
  • 4Goerres GW, Ziegler SI, Burger C, et al. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology, 2003, 226: 577-584.
  • 5Nakamoto Y, Chin BB, Kraitchman DL, et al. Effects of nonioruc intravenous contrast agents at PET/CT imaging: phantom and canine studies.Radiology, 2003, 227: 817-824.
  • 6Antoch G, Freudenberg LS, Egelhof T, et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med, 2002, 43: 1339-1342.
  • 7Erdi YE, Nehmeh SA, PanT, etal. The CT motion quantitation of lung lesions and its impact on PET measured SUVs. J Nucl Med, 2004, 45:1287-1292.
  • 8Boucher L, Rodrigue S, Lecomte R, et al. Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results. J Nucl Med,2004, 45: 214-219.
  • 9Osman MM, Sattah MV, Kayyat NM, etal. Bone metastases from nonsmall cell lung cancer: prevalence and patterns detected by true whole body ^18F-FDG PET. J Nucl Med, 2004, 45 Suppl: 25p-26p.
  • 10Vogel WV, Oyen WJG, Barentsz JO, et al. PET/CT: panacea, redundancy, or something in between? J Nucl Med, 2004, 45: 15S-24S.

共引文献16

同被引文献80

引证文献9

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部